Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BLISS GVS PHARMA vs ORCHID PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BLISS GVS PHARMA ORCHID PHARMA BLISS GVS PHARMA/
ORCHID PHARMA
 
P/E (TTM) x 13.1 41.8 31.4% View Chart
P/BV x 1.3 7.7 17.5% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 BLISS GVS PHARMA   ORCHID PHARMA
EQUITY SHARE DATA
    BLISS GVS PHARMA
Mar-23
ORCHID PHARMA
Mar-23
BLISS GVS PHARMA/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs91439 20.8%   
Low Rs67273 24.6%   
Sales per share (Unadj.) Rs72.2163.1 44.2%  
Earnings per share (Unadj.) Rs7.413.5 54.4%  
Cash flow per share (Unadj.) Rs9.227.0 34.0%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs84.0168.7 49.8%  
Shares outstanding (eoy) m104.1540.82 255.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.12.2 50.4%   
Avg P/E ratio x10.826.3 41.0%  
P/CF ratio (eoy) x8.713.2 65.6%  
Price / Book Value ratio x0.92.1 44.8%  
Dividend payout %6.80-   
Avg Mkt Cap Rs m8,26214,522 56.9%   
No. of employees `000NANA-   
Total wages/salary Rs m862654 131.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7,5166,659 112.9%  
Other income Rs m178194 91.5%   
Total revenues Rs m7,6946,853 112.3%   
Gross profit Rs m1,1731,235 95.0%  
Depreciation Rs m187548 34.1%   
Interest Rs m104329 31.5%   
Profit before tax Rs m1,061552 192.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2930-   
Profit after tax Rs m767552 138.9%  
Gross profit margin %15.618.5 84.2%  
Effective tax rate %27.70-   
Net profit margin %10.28.3 123.1%  
BALANCE SHEET DATA
Current assets Rs m6,9745,010 139.2%   
Current liabilities Rs m1,9333,719 52.0%   
Net working cap to sales %67.119.4 345.9%  
Current ratio x3.61.3 267.8%  
Inventory Days Days3957 67.4%  
Debtors Days Days1,8711,180 158.6%  
Net fixed assets Rs m4,5627,242 63.0%   
Share capital Rs m104408 25.5%   
"Free" reserves Rs m8,6466,478 133.5%   
Net worth Rs m8,7506,886 127.1%   
Long term debt Rs m4071,488 27.3%   
Total assets Rs m11,53512,252 94.1%  
Interest coverage x11.22.7 419.3%   
Debt to equity ratio x00.2 21.5%  
Sales to assets ratio x0.70.5 119.9%   
Return on assets %7.67.2 104.9%  
Return on equity %8.88.0 109.3%  
Return on capital %12.710.5 120.8%  
Exports to sales %081.9 0.0%   
Imports to sales %037.6 0.0%   
Exports (fob) Rs mNA5,452 0.0%   
Imports (cif) Rs mNA2,501 0.0%   
Fx inflow Rs m5,6185,452 103.1%   
Fx outflow Rs m1,2252,726 44.9%   
Net fx Rs m4,3942,726 161.2%   
CASH FLOW
From Operations Rs m343183 187.1%  
From Investments Rs m-78-312 24.8%  
From Financial Activity Rs m-249312 -80.0%  
Net Cashflow Rs m30183 16.5%  

Share Holding

Indian Promoters % 35.0 69.8 50.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 22.0 18.6 117.8%  
FIIs % 15.4 4.1 371.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 65.0 30.2 215.6%  
Shareholders   40,758 36,931 110.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BLISS GVS PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BLISS GVS PHARMA vs Orchid Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BLISS GVS PHARMA vs Orchid Pharma Share Price Performance

Period BLISS GVS PHARMA Orchid Pharma S&P BSE HEALTHCARE
1-Day -1.31% -0.40% 1.18%
1-Month -9.12% -14.06% -0.75%
1-Year 58.26% 173.54% 61.82%
3-Year CAGR 3.89% -23.64% 18.16%
5-Year CAGR -8.75% 184.58% 19.79%

* Compound Annual Growth Rate

Here are more details on the BLISS GVS PHARMA share price and the Orchid Pharma share price.

Moving on to shareholding structures...

The promoters of BLISS GVS PHARMA hold a 35.0% stake in the company. In case of Orchid Pharma the stake stands at 69.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BLISS GVS PHARMA and the shareholding pattern of Orchid Pharma.

Finally, a word on dividends...

In the most recent financial year, BLISS GVS PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.8%.

Orchid Pharma paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of BLISS GVS PHARMA, and the dividend history of Orchid Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.